Scientists use CRISPR to shrink goldenberry plants for easier farming

Researchers at Cold Spring Harbor Laboratory have employed CRISPR gene-editing to create more compact goldenberry plants, reducing their size by about 35 percent to simplify cultivation. This innovation targets the fruit's unruly growth while preserving its nutritious, sweet-tart flavor. The approach aims to enable large-scale farming and enhance crop resilience amid climate challenges.

Goldenberries, a small fruit related to tomatoes and primarily grown in South America, have gained attention for their nutritional value and balanced taste. However, their bushy, sprawling nature has long hindered efficient harvesting, as farmers rely on largely undomesticated varieties.

A team led by postdoc Miguel Santo Domingo Martinez in Zachary Lippman's lab at Cold Spring Harbor Laboratory addressed this by applying CRISPR to edit genes previously targeted in tomatoes and groundcherries. The modifications resulted in plants roughly a third shorter, allowing denser planting and easier management in agricultural settings.

"These massive, sprawling plants in an agricultural setting are cumbersome for harvest," explained greenhouse technician Blaine Fitzgerald.

To maintain flavor, the researchers sampled fruits directly from fields, tasting hundreds to select the best performers. After several generations of selective breeding, they developed two new lines combining compact stature with robust taste, though the fruits are slightly smaller.

The work builds on millennia of traditional selective breeding that shaped modern crops but accelerates the process for undomesticated species. "By using CRISPR, you open up paths to new and more resilient food options," Fitzgerald said. "In an era of climate change and increasing population size, bringing innovation to agricultural production is going to be a huge path forward."

Future efforts could focus on boosting fruit size or resistance to diseases and drought, according to Santo Domingo: "We can use these modern tools to domesticate undomesticated crops."

Regulatory approval remains the next hurdle before seeds reach growers for broader production. The findings appear in the journal PLANTS, PEOPLE, PLANET.

Makala yanayohusiana

Illustration of UC San Diego researchers' CRISPR pPro-MobV system spreading through bacterial biofilms to disable antibiotic resistance genes in a lab setting.
Picha iliyoundwa na AI

UC San Diego researchers describe a gene-drive-like CRISPR system designed to reduce antibiotic resistance in bacteria

Imeripotiwa na AI Picha iliyoundwa na AI Imethibitishwa ukweli

Researchers at the University of California San Diego report they have developed a second-generation CRISPR-based “Pro-Active Genetics” system, called pPro-MobV, that is designed to spread between bacteria and disable antibiotic-resistance genes, including inside hard-to-treat biofilms.

Researchers in Israel have used CRISPR gene editing to deactivate a gene that produces bitter chemicals in grapefruit, potentially making the fruit more appealing to consumers. This innovation could expand the market for citrus and combat the devastating citrus greening disease by enabling cold-hardy, edible varieties. The approach aims to shift citrus farming to temperate regions like northern Europe.

Imeripotiwa na AI

Chinese and Australian researchers used the CRISPR/Cas9 tool to silence two genes, creating a tomato that emits the aroma of buttered popcorn. The tomatoes appear ordinary but carry a surprisingly sweet scent reminiscent of premium fragrant rice. The study was published online on January 24 in the Journal of Integrative Agriculture.

Researchers from New England Biolabs and Yale University have developed the first fully synthetic system for engineering bacteriophages targeting Pseudomonas aeruginosa, a major antibiotic-resistant bacterium. Published in PNAS, the method uses digital DNA sequences to build viruses from scratch, bypassing traditional challenges in phage modification. This innovation aims to accelerate therapies against global antibiotic resistance threats.

Imeripotiwa na AI

A genetic technology called a gene drive has shown promise in preventing malaria transmission by mosquitoes during lab tests in Tanzania. Researchers modified local mosquitoes to produce antimalarial proteins, demonstrating effective inhibition of parasites from infected children. The findings suggest the approach could work in the field if released.

An extract from Nitraria roborowskii, a desert shrub used in traditional Chinese medicine, improved insulin sensitivity and metabolic markers in diabetic mice by reactivating the PI3K/AKT pathway, according to a peer‑reviewed study in the Chinese Journal of Modern Applied Pharmacy and a summary posted on ScienceDaily.

Imeripotiwa na AI

Scientists are using DNA testing to identify the plant sources of honey, detect adulteration, and reveal hive pathogens. This method helps distinguish pure local honey from imported or syrup-contaminated products. Advances in genetic sequencing are making these detections more accurate and accessible.

Jumatano, 11. Mwezi wa tatu 2026, 14:42:22

Hornwort's RbcS-STAR protein clusters Rubisco for more efficient photosynthesis

Jumamosi, 28. Mwezi wa pili 2026, 14:28:17

Scientists create caffeine-triggered CRISPR system for disease treatment

Jumamosi, 21. Mwezi wa pili 2026, 07:44:34

New book critiques commercial genetic testing's risks

Alhamisi, 19. Mwezi wa pili 2026, 11:52:25

Scientists identify gene resisting Panama disease in wild bananas

Ijumaa, 23. Mwezi wa kwanza 2026, 05:17:42

Hybrid pests evolving in Brazil threaten global crops

Jumamosi, 10. Mwezi wa kwanza 2026, 00:46:28

Jennifer Doudna cofounds startup for tailored gene-editing treatments

Jumatatu, 5. Mwezi wa kwanza 2026, 17:05:03

Wei Zhao introduces CRISPR idea for flu at symposium

Jumatatu, 5. Mwezi wa kwanza 2026, 00:35:01

CRISPR-based epigenome editing switches genes on by removing methyl tags, without cutting DNA

Jumatano, 10. Mwezi wa kumi na mbili 2025, 04:43:46

Martin Morgenstern: genetic editing is the future of medicine

Jumatatu, 17. Mwezi wa kumi na moja 2025, 07:51:36

CRISPR knockout of NRF2 re-sensitizes drug‑resistant lung tumors in preclinical study

 

 

 

Tovuti hii inatumia vidakuzi

Tunatumia vidakuzi kwa uchambuzi ili kuboresha tovuti yetu. Soma sera ya faragha yetu kwa maelezo zaidi.
Kataa